TALON Phase IIIb Study: 32 Week Primary Results of Brolucizumab Using Treat and Extend for Neovascular Age Related Macular Degeneration.Carl Regillo, Peter K Kaiser, Peter J Kertes,Mark Gillies, Tina Maio-Twofoot, Divya D'Souza, Siegbert Guenther, David Lawrence, Frank G HolzOphthalmology Retina（2025）引用 0|浏览0AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
